BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26850323)

  • 1. High expression of CD38, CD69, CD95 and CD154 biomarkers in cultured peripheral T lymphocytes correlates with an increased risk of acute rejection in liver allograft recipients.
    Boix F; Millan O; San Segundo D; Mancebo E; Rimola A; Fabrega E; Fortuna V; Mrowiec A; Castro-Panete MJ; Peña Jde L; Llorente S; Minguela A; Bolarin JM; Paz-Artal E; Lopez-Hoyos M; Brunet M; Muro M
    Immunobiology; 2016 May; 221(5):595-603. PubMed ID: 26850323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High proportion of CD95(+) and CD38(+) in cultured CD8(+) T cells predicts acute rejection and infection, respectively, in kidney recipients.
    Mancebo E; Castro MJ; Allende LM; Talayero P; Brunet M; Millán O; Guirado L; López-Hoyos M; San Segundo D; Rodrigo E; Muñoz P; Boix Giner F; Llorente Viñas S; Muro-Amador M; Paz-Artal E
    Transpl Immunol; 2016 Feb; 34():33-41. PubMed ID: 26773856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of CD154 (CD40L) expression in peripheral blood mononuclear cells of healthy subjects in liver allograft recipients and X-linked hyper-IgM syndrome.
    Bartlett A; McCall J; Ameratunga R; Munn S
    Clin Transplant; 2000 Dec; 14(6):520-8. PubMed ID: 11127303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of central memory regulatory T cells allows detection of liver recipients at risk of early acute rejection within the first month after transplantation.
    Boix-Giner F; Millan O; San Segundo D; Muñoz-Cacho P; Mancebo E; Llorente S; Rafael-Valdivia L; Rimola A; Fábrega E; Mrowiec A; Allende L; Minguela A; Bolarín JM; Paz-Artal E; López-Hoyos M; Brunet M; Muro M
    Int Immunol; 2016 Feb; 28(2):55-64. PubMed ID: 26270267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of peripheral CD154
    Boix F; Legaz I; Minhas A; Alfaro R; Jiménez-Coll V; Mrowiec A; Martínez-Banaclocha H; Galián JA; Botella C; Moya-Quiles MR; Sanchez-Bueno F; Robles R; de la Peña-Moral J; Ramirez P; Pons JA; Minguela A; Muro M
    Clin Exp Immunol; 2021 Feb; 203(2):315-328. PubMed ID: 33025622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation.
    Boleslawski E; BenOthman S; Grabar S; Correia L; Podevin P; Chouzenoux S; Soubrane O; Calmus Y; Conti F
    Clin Transplant; 2008; 22(4):494-501. PubMed ID: 18565100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD69 expression on peripheral CD8 T cells correlates with acute rejection in renal transplant recipients.
    Posselt AM; Vincenti F; Bedolli M; Lantz M; Roberts JP; Hirose R
    Transplantation; 2003 Jul; 76(1):190-5. PubMed ID: 12865808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of peripheral blood CD4 and CD8 lymphocyte subsets, CD69 expression and histologic rejection grade as diagnostic markers for the presence of cardiac allograft rejection.
    Creemers P; Brink J; Wainwright H; Moore K; Shephard E; Kahn D
    Transpl Immunol; 2002 Nov; 10(4):285-92. PubMed ID: 12507400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD28 expression on peripheral blood T lymphocytes after orthotopic liver transplant: upregulation in acute rejection.
    García-Alonso AM; Minguela A; Muro M; Ontañón J; Torío A; Marín L; López-Segura P; Miras M; Alvarez-López MR
    Hum Immunol; 1997 Mar; 53(1):64-72. PubMed ID: 9127149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.
    Schowengerdt KO; Fricker FJ; Bahjat KS; Kuntz ST
    Transplantation; 2000 May; 69(10):2102-7. PubMed ID: 10852605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-Cell Cytokines as Predictive Markers of the Risk of Allograft Rejection.
    Brunet M; Millán López O; López-Hoyos M
    Ther Drug Monit; 2016 Apr; 38 Suppl 1():S21-8. PubMed ID: 26444655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 and CXCL9 serum protein levels predict the risk of clinically significant allograft rejection after liver transplantation.
    Raschzok N; Reutzel-Selke A; Schmuck RB; Morgul MH; Gauger U; Prabowo KA; Tannus LM; Leder A; Struecker B; Boas-Knoop S; Bartels M; Jonas S; Lojewski C; Puhl G; Seehofer D; Bahra M; Pascher A; Pratschke J; Sauer IM
    Liver Transpl; 2015 Sep; 21(9):1195-207. PubMed ID: 25950774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.
    Ashokkumar C; Sun Q; Ningappa M; Higgs BW; Mazariegos G; Zeevi A; Sindhi R
    Transplantation; 2015 Jan; 99(1):164-70. PubMed ID: 25531894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation.
    Wang Y; Liu Y; Han R; Li Q; Yao Z; Niu W; Yuan Y; Tang Z; Zhu Z; Shen Z
    J Gastroenterol Hepatol; 2010 Jan; 25(1):138-42. PubMed ID: 19817952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory blockade prevents early rejection, promotes lymphocyte apoptosis, and inhibits the upregulation of intragraft interleukin-6 in an orthotopic liver transplant model in the rat.
    Bartlett AS; McCall JL; Ameratunga R; Howden B; Yeong ML; Benjamin CD; Hess D; Peach R; Munn SR
    Liver Transpl; 2002 May; 8(5):458-68. PubMed ID: 12004346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of the post transplant blood lymphocyte phenotype subsets as a marker of rejection in renal allograft recipients.
    Wramner L; Mjörnstedt L; Blohmé I; Tufveson G; Söderström T; Olausson M
    Scand J Immunol; 1995 Aug; 42(2):275-81. PubMed ID: 7631161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher Expression of Activated CD8
    Boix F; Jimenez-Coll V; Legaz I; Alfaro R; Moya-Quiles MR; Peña-Moral J; Minguela A; Llorente S; Muro M
    Front Biosci (Landmark Ed); 2023 Jun; 28(6):119. PubMed ID: 37395036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study of biomarkers of immune response in lung transplant recipients.
    San Segundo D; Brunet M; Ballesteros MA; Millán O; Muro M; Castro MJ; Miñambres E; López-Hoyos M
    Transplant Proc; 2012 Nov; 44(9):2666-8. PubMed ID: 23146488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should IFN-γ, IL-17 and IL-2 be considered predictive biomarkers of acute rejection in liver and kidney transplant? Results of a multicentric study.
    Millán O; Rafael-Valdivia L; San Segundo D; Boix F; Castro-Panete MJ; López-Hoyos M; Muro M; Valero-Hervás D; Rimola A; Navasa M; Muñoz P; Miras M; Andrés A; Guirado L; Pascual J; Brunet M
    Clin Immunol; 2014 Oct; 154(2):141-54. PubMed ID: 25088788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyte activation markers may predict the presence of donor specific alloreactivity in pediatric living related liver transplant recipients.
    Ekong UD; Luo X; Yu M; Wang D; Miller SD; O'Gorman MR
    Hum Immunol; 2011 May; 72(5):392-7. PubMed ID: 21315129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.